Sectors & IndustriesHealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2025)
Top health information service stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...
B
Health Information Services is Zen Rated B and is the 45th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
DD Score
Valuation Score
Financials Score
Forecast Score
Performance Score
Dividends Score
NUTX
NUTEX HEALTH INC
24
29
29
0
40
TBRG
TRUBRIDGE INC
9
14
29
0
0
0
GDRX
GOODRX HOLDINGS INC
41
29
71
44
20
SPOK
SPOK HOLDINGS INC
46
71
57
11
30
60
PGNY
PROGYNY INC
39
14
57
44
40

Upgrade to Premium to View More

Use Due Diligence Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail.

Already have a premium account? Sign In

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Nutex Health (NASDAQ:NUTX)


Nutex Health (NASDAQ:NUTX) is the #1 top health information service stock out of 55 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Nutex Health (NASDAQ:NUTX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: D, Financials: C, and AI: C.

Nutex Health (NASDAQ:NUTX) has a Due Diligence Score of 24, which is -2 points lower than the health information service industry average of 26. Although this number is below the industry average, our proven quant model rates NUTX as a "A".

NUTX passed 8 out of 33 due diligence checks and has weak fundamentals. Nutex Health has seen its stock return 1,717.69% over the past year, overperforming other health information service stocks by 1,789 percentage points.

Nutex Health has an average 1 year price target of $80.00, a downside of -27.25% from Nutex Health's current stock price of $109.97.

Nutex Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Nutex Health, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Trubridge (NASDAQ:TBRG)


Trubridge (NASDAQ:TBRG) is the #2 top health information service stock out of 55 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Trubridge (NASDAQ:TBRG) is: Value: C, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Trubridge (NASDAQ:TBRG) has a Due Diligence Score of 9, which is -17 points lower than the health information service industry average of 26. Although this number is below the industry average, our proven quant model rates TBRG as a "A".

TBRG passed 3 out of 38 due diligence checks and has weak fundamentals. Trubridge has seen its stock return 229.49% over the past year, overperforming other health information service stocks by 301 percentage points.

Trubridge has an average 1 year price target of $28.50, an upside of 9.49% from Trubridge's current stock price of $26.03.

Trubridge stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Trubridge, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Goodrx Holdings (NASDAQ:GDRX)


Goodrx Holdings (NASDAQ:GDRX) is the #3 top health information service stock out of 55 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Goodrx Holdings (NASDAQ:GDRX) is: Value: B, Growth: B, Momentum: C, Sentiment: C, Safety: C, Financials: A, and AI: C.

Goodrx Holdings (NASDAQ:GDRX) has a Due Diligence Score of 41, which is 15 points higher than the health information service industry average of 26.

GDRX passed 13 out of 33 due diligence checks and has strong fundamentals. Goodrx Holdings has seen its stock lose -34.79% over the past year, overperforming other health information service stocks by 37 percentage points.

Goodrx Holdings has an average 1 year price target of $6.13, an upside of 32.29% from Goodrx Holdings's current stock price of $4.63.

Goodrx Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Goodrx Holdings, 66.67% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the health information service stocks with highest dividends?

Out of 6 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.72%, which is 6 percentage points higher than the health information service industry average of 2.84%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 168.9% indicates that its high dividend yield might not be sustainable for the long-term.

2. Premier (NASDAQ:PINC)


Premier (NASDAQ:PINC) has an annual dividend yield of 4.13%, which is 1 percentage points higher than the health information service industry average of 2.84%. Premier's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Premier's dividend has shown consistent growth over the last 10 years.

Premier's dividend payout ratio of -763.6% indicates that its dividend yield might not be sustainable for the long-term.

3. So Young International (NASDAQ:SY)


So Young International (NASDAQ:SY) has an annual dividend yield of 3.23%, which is the same as the health information service industry average of 2.84%.

So Young International's dividend payout ratio of -3.3% indicates that its dividend yield might not be sustainable for the long-term.

Why are health information service stocks down?

Health information service stocks were down -3.86% in the last day, and down -3.59% over the last week. Genedx Holdings was the among the top losers in the health information services industry, dropping -42.85% yesterday.

GeneDx Holdings shares are trading lower. The company reported Q1 financial results.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Goodrx Holdings (NASDAQ:GDRX)


Goodrx Holdings (NASDAQ:GDRX) is the most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Goodrx Holdings has a valuation score of 29, which is 14 points higher than the health information service industry average of 15. It passed 2 out of 7 valuation due diligence checks.

Goodrx Holdings's stock has dropped -34.79% in the past year. It has overperformed other stocks in the health information service industry by 37 percentage points.

2. National Research (NASDAQ:NRC)


National Research (NASDAQ:NRC) is the second most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

National Research has a valuation score of 57, which is 42 points higher than the health information service industry average of 15. It passed 4 out of 7 valuation due diligence checks.

National Research's stock has dropped -66.83% in the past year. It has overperformed other stocks in the health information service industry by 5 percentage points.

3. Solventum (NYSE:SOLV)


Solventum (NYSE:SOLV) is the third most undervalued health information service stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Solventum has a valuation score of 43, which is 28 points higher than the health information service industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Solventum's stock has gained 1.71% in the past year. It has overperformed other stocks in the health information service industry by 73 percentage points.

Are health information service stocks a good buy now?

47.22% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 60.79% over the next year.

4.55% of health information service stocks have a Zen Rating of A (Strong Buy), 27.27% of health information service stocks are rated B (Buy), 50% are rated C (Hold), 13.64% are rated D (Sell), and 4.55% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 40.3x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.